NAI is excited to present a prime investment opportunity at 3105 Willow Lane, in Thousand Oaks, California. The ±25,564 square-foot Industrial/Research and Development facility is located within the heart of Thousand Oaks, just off the 101 Freeway at Hampshire Blvd. The property is currently 100% occupied by Natren Probiotics, a respected leader in the health and wellness sector, which has owned and occupied the building since 1990. In 2018 Natren invested significant capital having expanded their facility & it’s capabilities, to its current size, ensuring the facility will meet their operational demands for many years to come. Natren will enter into a long-term absolute NNN leaseback at the close of escrow, providing investors with a stable and predictable income stream. The property is situated in Thousand Oaks, which is prominent hub for biotech, research, and development, with a strong tenant base that includes major industry players such as Amgen and Alexandria Real Estate Equities. This makes the location especially attractive for businesses in the life sciences and R&D sectors. Thousand Oaks boasts a robust infrastructure, convenient proximity to top-tier universities, and a heavy concentration of other biotech industry leaders, creating a highly desirable environment for these businesses. Conveniently positioned immediately off the 101 Freeway, the property offers exceptional accessibility to both Ventura and Los Angeles counties, providing direct access to key transportation routes and regional markets. With a long-term, entrenched, creditworthy tenant in place coupled with their highly desirable location, this offering represents a rare opportunity to acquire a fully leased asset in one of Southern California’s most sought-after business hubs.